Skip to main content

Table 4 Cox regression model of various prognostic factors for disease specific survival

From: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience

Variable

All patients

Univariate analysis

Multivariate analysis

RR (95 % CI)

p

RR (95 % CI)

p

Age

 ≤45 years

1.05 (0.7–1.3)

 

1.07 (0.8–1.3)

 

 ≥45 years

1.10 (0.8–1.4)

0.6

1.10 (0.9–1.3)

0.06

Gender

 Female

1.07 (0.9–1.4)

 

1.05 (0.7–1.3)

 

 Male

1.05 (0.7–1.3)

0.6

1.40 (1.2–1.6)

0.05

Histopathologic variants

 Classic

1.05 (0.7–1.2)

 

1.20 (0.8–1.6)

 

 Follicular

1.00 (0.6–1.8)

 

1.18 (0.7–1.5)

 

 Hurthle cell

1.30 (1.1–1.7)

 

2.00 (1.6–2.4)

 

 Tall cell

2.70 (1.6–4.5)

 

2.82 (2.4–4.6)

 

 Sclerosing

1.80 (1.6–2.9)

<0.0001

2.00 (1.6–3.0)

<0.0001

Multifocal

 Yes

3.1 (2.8–4.2)

 

2.94 (2.2–3.4)

 

 No

1.0 (0.8–1.2)

<0.0001

1.07 (0.9–1.3)

<0.0001

Surgical margins

 Positive

1.10 (0.9–1.4)

 

1.20 (0.8–1.6)

 

 Negative

1.07 (0.9–1.4)

0.7

1.17 (0.6–1.2)

0.68

ETE

 Yes

4.2 (3.5–5.1)

 

3.31 (1.7–4.2)

 

 No

1.05 (0.7–1.1)

<0.0001

1.17 (0.9–1.4)

<0.0001

LVSI

 Yes

2.0 (1.7–2.9)

 

1.81 (1.6–2.8)

 

 No

1.0 (0.8–1.2)

0.02

1.04 (0.9–1.5)

0.03

Lymph nodes

 Positive

4.45 (3.7–6.8)

 

3.74 (3.4–5.9)

 

 Negative

1.17 (0.9–1.4)

<0.0001

1.01 (0.8–1.3)

<0.0001

Mean postoperative TG

 ≤2 ng/ml

1.01 (0.7–1.2)

 

1.05 (0.7–1.2)

 

 >2 ng/ml

1.04 (0.9–1.5)

0.6

1.00 (0.6–1.8)

0.6

RAI ablation

 Yes

0.35 (0.2–0.7)

 

0.30 (0.2–0.8)

 

 No

1.09 (1.0–1.9)

<0.0001

1.00 (0.6–1.8)

<0.0001

  1. I-131 radioactive iodine 131, RR relative risk, CI confidence interval, ETE extra-thyroidal extension, LVSI lymphovascular space invasion, TG thyroglobulin, RAI radioactive iodine